ERAS Erasca, Inc.

HealthcareBiotechnology
$10.40
▼ 4.59%
34
QScore Signal
Short
Confidence: MEDIUM
Long-Term
29
Short-Term
40

Value

29
P/E-23.68
8
P/B9.07
42
P/S0.00
70
EV/EBITDA-25.37
5

Growth

39
Revenue Growth0.0%
28
EPS Growth36.2%
46
FCF Growth27.6%
47

Momentum

57
12-Month Return732.0%
100
3-Month Return-12.5%
40
1-Month Return-38.6%
0
RSI (14)30.58
50
50/200 MABullish
75

Profitability

19
ROE-34.5%
45
ROA-31.4%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-3.0%
0

Risk

25
Beta0.68
55
60-Day Volatility160.5%
0

Generated 5/7/2026, 9:59:04 PM · How is this calculated?

QScore Analysis